01/03/2024 | Press release | Distributed by Public on 01/03/2024 16:45
Audience
What is the problem?
Tested Products
To date, the FDA has tested 9 samples, representing the 9 different products listed below, and found them to contain yellow oleander. Tejocote root dietary supplements that were sampled and determined by the FDA to be substituted with toxic yellow oleander:
SELLING FIRM | BRAND | WEBSITE PURCHASED FROM | PRODUCT |
---|---|---|---|
Amazon.com |
Alipotec Tejocote Root Nutraholics ELV Tejocote Root ELV Nutraholics Mexican Tejocote Root ELVPOTEC Tejocote Root |
Amazon.com |
|
Global Mix, Inc. |
Science of Alpha Mexican Tejocote Root Niwali Raiz de Tejocote |
Etsy.com |
|
Innovacion Natural, LLC |
Alipotec Tejocote Root |
Innovacionnatural.com |
|
Pastor-Villareal, Inc. |
Tejocotex |
Amazon.com |
|
Alipotec South TX World Green Nutrition, Inc. |
ELV Alipotec Raiz de Tejocote |
alipotecus.com |
Recommendations for consumers
Summary and Scope of the Problem
In September 2023, the Centers for Disease Control and Prevention published a report of several tejocote root products found to be substituted with toxic yellow oleander. Based on this report, the FDA initiated an investigation to sample and test additional tejocote root products. To date, the FDA has tested 9 samples, representing the 9 different products listed above, and found them to contain yellow oleander. Additional sample analysis is pending.
Based on the FDA's sampling and testing results thus far, the FDA is also concerned that other products marketed as tejocote (including with other names such as Crataegus mexicana, Raiz de Tejocote, and Mexican Hawthorn) may contain yellow oleander. Consuming yellow oleander can cause severe adverse health effects and be potentially fatal.
Actions
The FDA is actively working with the third-party platforms where these products are sold.
The FDA's investigation is ongoing, and the FDA will continue to provide information on any further actions as it becomes available. Products may be added to this advisory. The FDA is working to further address the concerns related to these products and monitoring the market for adverse events, product complaints, and other emerging issues.
Who to Contact
Health care professionals, patients and consumers are encouraged to report complaints and cases of exposure and adverse events to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.
To report a complaint or adverse event (illness or serious allergic reaction), you can